Pharvaris N.V. (PHVS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Pharvaris N.V., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$32.82
+2.72% today
Market cap
$2.2B
Overall quality
—
Kronos AI 30-day
+1.2%
4 of 8 simulated paths end higher
Pharvaris N.V. (PHVS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $2.2B. It trades at $32.82, up 2.72% today. 12 analysts' average target of $61.33 implies +86.9% from today's price. Kronos AI's 30-day forecast is +1.2% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $61.33 |
| Low – high | $44.00 – $79.00 |
| Analysts | 12 |
| Upside to average | +86.9% |
Kronos AI 30-day forecast
| Expected close | $32.33 (+1.2%) |
| Likely range | −4.1% … +8.4% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.